Targeted proteomic search reveals new actors in the synaptic and lysosomal dysfunction in genetic FTD, a GENFI study.
Sophia Weiner(Institute of Neurobiology), Aitana Sogorb‐Esteve(UK Dementia Research Institute), Sandro Sorbi(University of Florence), Caroline Graff(Karolinska Institutet), Joel Simrén(Sahlgrenska University Hospital), Maria Carmela Tartaglia, James B. Rowe(MRC Cognition and Brain Sciences Unit), Kaj Blennow(Sahlgrenska University Hospital), Alexander Gerhard(University of Manchester), Christopher Butler(Pontificia Universidad Católica de Chile), Matthis Synofzik(University of Tübingen), Imogen J. Swift(UK Dementia Research Institute), Johannes Levin(The University of Melbourne), Alexandre de Mendonça(University of Lisbon), Isabelle Le Ber(Inserm), Raquel Sánchez‐Valle(Universitat de Barcelona), Mathias Sauer(Sahlgrenska University Hospital), Harro Seelaar(Erasmus University Rotterdam), Pietro Tiraboschi(Mayo Clinic in Florida), Florence Pasquier, Isabel Santana(University of Coimbra), Lize C. Jiskoot(Erasmus MC), Jonathan D. Rohrer(UK Dementia Research Institute), Markus Otto(Universität Ulm), Rik Vandenberghe(KU Leuven), Elizabeth Finger(Western University), Carolin Heller(UK Dementia Research Institute), Daniela Galimberti(University of Milan), Mario Masellis(Sunnybrook Health Science Centre), Fermín Moreno(Instituto de Salud Carlos III), Robert Laforce(Université Laval), Barbara Borroni(Anna Needs Neuroblastoma Answers), Frederika Malichova(UK Dementia Research Institute), Simon Ducharme(Montreal Neurological Institute and Hospital), John C. van Swieten(Erasmus MC), Kathryn Knowles(UK Dementia Research Institute), Henrik Zetterberg(University of Gothenburg), Johan Gobom(Sahlgrenska University Hospital)
Cited by 0
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k